1. Executive Summary |
2. Global Multiplex Assays Market Introduction |
2.1. Global Multiplex Assays Market – Taxonomy |
2.2. Global Multiplex Assays Market –Definitions |
2.2.1. Product Type |
2.2.2. Assay Type |
2.2.3. Technology |
2.2.4. Application |
2.2.5. End User |
3. Global Multiplex Assays Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Multiplex Assays Market Dynamic Factors – Impact Analysis |
3.6. Global Multiplex Assays Market – Competition Landscape |
4. Global Multiplex Assays Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Multiplex Assays Market, By Product Type, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn) |
5.1. Reagents & Consumables |
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Instruments & Accessories |
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Software & Services |
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Multiplex Assays Market, By Assay Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
6.1. Protein Based Multiplex Assays |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Nucleic Acid-Based Multiplex Assay |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Other Multiplex Assays |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Multiplex Assays Market Forecast, By Technology,2017–2021and Forecast, 2022–2028 (Revenue, USD Mn) |
7.1. Flow Cytometry |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Fluorescence Detection |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Luminescence |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Multiplex Real-Time PCR |
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Multiplex Assays Market Forecast, By Application, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
8.1. Research & Development |
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Clinical Diagnostics |
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9. Global Multiplex Assays Market, By End User, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
9.1. Pharmaceutical & Biotechnology Companies |
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Hospitals & Clinics |
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Diagnostic and Reference Laboratories |
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Academic and Research Institutes |
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Others |
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. Global Multiplex Assays Market Forecast, By Region, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn) |
10.1. North America |
10.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.1.3. Market Opportunity Analysis |
10.2. Europe |
10.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.2.3. Market Opportunity Analysis |
10.3. Asia-Pacific |
10.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.3.3. Market Opportunity Analysis |
10.4. Latin America |
10.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.4.3. Market Opportunity Analysis |
10.5. Middle East and Africa |
10.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.5.3. Market Opportunity Analysis |
10.6. Global Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Region, 2022 – 2028 |
11. North America Multiplex Assays MarketAnalysis,2017–2021and Forecast, 2022–2028(Revenue, USD Mn) |
11.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Reagents & Consumables |
11.1.2. Instruments & Accessories |
11.1.3. Software & Services |
11.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Protein Based Multiplex Assays |
11.2.2. Nucleic Acid-Based Multiplex Assay |
11.2.3. Other Multiplex Assays |
11.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Flow Cytometry |
11.3.2. Fluorescence Detection |
11.3.3. Luminescence |
11.3.4. Multiplex Real-Time PCR |
11.3.5. Others |
11.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Research & Development |
11.4.2. Clinical Diagnostics |
11.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Pharmaceutical & Biotechnology Companies |
11.5.2. Hospitals and Clinics |
11.5.3. Diagnostic and Reference Laboratories |
11.5.4. Academic and Research Institutes |
11.5.5. Others |
11.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.6.1. USA |
11.6.2. Canada |
11.7. North America Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User and Country, 2022 – 2028 |
11.8. North America Multiplex Assays Market Dynamics – Trends |
12. Europe Multiplex Assays Market Analysis, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn) |
12.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Reagents & Consumables |
12.1.2. Instruments & Accessories |
12.1.3. Software & Services |
12.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Protein Based Multiplex Assays |
12.2.2. Nucleic Acid-Based Multiplex Assay |
12.2.3. Other Multiplex Assays |
12.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Flow Cytometry |
12.3.2. Fluorescence Detection |
12.3.3. Luminescence |
12.3.4. Multiplex Real-Time PCR |
12.3.5. Others |
12.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Research & Development |
12.4.2. Clinical Diagnostics |
12.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Pharmaceutical & Biotechnology Companies |
12.5.2. Hospitals and Clinics |
12.5.3. Diagnostic and Reference Laboratories |
12.5.4. Academic and Research Institutes |
12.5.5. Others |
12.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.6.1. Germany |
12.6.2. UK |
12.6.3. France |
12.6.4. Spain |
12.6.5. Italy |
12.6.6. Rest of Europe |
12.7. Europe Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Country, 2022 – 2028 |
12.8. Europe Multiplex Assays Market Dynamics – Trends |
13. Asia-Pacific Multiplex Assays Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
13.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Reagents & Consumables |
13.1.2. Instruments & Accessories |
13.1.3. Software & Services |
13.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Protein Based Multiplex Assays |
13.2.2. Nucleic Acid-Based Multiplex Assay |
13.2.3. Other Multiplex Assays |
13.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Flow Cytometry |
13.3.2. Fluorescence Detection |
13.3.3. Luminescence |
13.3.4. Multiplex Real-Time PCR |
13.3.5. Others |
13.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Research & Development |
13.4.2. Clinical Diagnostics |
13.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Pharmaceutical & Biotechnology Companies |
13.5.2. Hospitals and Clinics |
13.5.3. Diagnostic and Reference Laboratories |
13.5.4. Academic and Research Institutes |
13.5.5. Others |
13.6. Country Analysis2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.6.1. Japan |
13.6.2. China |
13.6.3. India |
13.6.4. ASEAN |
13.6.5. Australia & New Zealand |
13.6.6. Rest of Asia-Pacific |
13.7. Asia-Pacific Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Country,2022 – 2028 |
13.8. Asia-Pacific Multiplex Assays Market Dynamics – Trends |
14. Latin America Multiplex Assays Market Analysis,2017 – 2021 and Forecast, 2022–2028(Revenue, USD Mn) |
14.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Reagents & Consumables |
14.1.2. Instruments & Accessories |
14.1.3. Software & Services |
14.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Protein Based Multiplex Assays |
14.2.2. Nucleic Acid-Based Multiplex Assay |
14.2.3. Other Multiplex Assays |
14.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Flow Cytometry |
14.3.2. Fluorescence Detection |
14.3.3. Luminescence |
14.3.4. Multiplex Real-Time PCR |
14.3.5. Others |
14.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Research & Development |
14.4.2. Clinical Diagnostics |
14.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Pharmaceutical & Biotechnology Companies |
14.5.2. Hospitals and Clinics |
14.5.3. Diagnostic and Reference Laboratories |
14.5.4. Academic and Research Institutes |
14.5.5. Others |
14.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.6.1. Brazil |
14.6.2. Mexico |
14.6.3. Argentina |
14.6.4. Rest of Latin America |
14.7. Latin America Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Country, 2022 – 2028 |
14.8. Latin America Multiplex Assays Market Dynamics – Trends |
15. Middle East and Africa Multiplex Assays Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
15.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
15.1.1. Reagents & Consumables |
15.1.2. Instruments & Accessories |
15.1.3. Software & Services |
15.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.2.1. Protein Based Multiplex Assays |
15.2.2. Nucleic Acid-Based Multiplex Assay |
15.2.3. Other Multiplex Assays |
15.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.3.1. Flow Cytometry |
15.3.2. Fluorescence Detection |
15.3.3. Luminescence |
15.3.4. Multiplex Real-Time PCR |
15.3.5. Others |
15.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.4.1. Research & Development |
15.4.2. Clinical Diagnostics |
15.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.5.1. Pharmaceutical & Biotechnology Companies |
15.5.2. Hospitals and Clinics |
15.5.3. Diagnostic and Reference Laboratories |
15.5.4. Academic and Research Institutes |
15.5.5. Others |
15.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
15.6.1. Gulf Cooperation Council (GCC) Countries |
15.6.2. Israel |
15.6.3. South Africa |
15.6.4. Rest of MEA |
15.7. MEA Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Country, 2022 – 2028 |
15.8. MEA Multiplex Assays Market Dynamics – Trends |
16. Competition Landscape |
16.1. Strategic Dashboard of Top Market Players |
16.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Assay Types, Key Developments, Strategies, and SWOT Analysis) |
16.2.1. Thermo Fisher Scientific Inc. |
16.2.2. Illumina Inc. |
16.2.3. Bio-Rad Laboratories Inc. |
16.2.4. QIAGEN N.V. |
16.2.5. Becton, Dickinson and Company |
16.2.6. Abcam PLC |
16.2.7. Seegene Inc. |
16.2.8. Randox Laboratories Ltd. |
16.2.9. Merck KGaA |
16.2.10. Promega Corporation |
17. Research Methodology |
18. Key Assumptions and Acronyms |